GLP-1 agonists like semaglutide have revolutionized weight-loss medications. For some people, weight loss can be elusive, even when they’re eating well, exercising, and doing all the “right things.” For these people, effective weight-loss medications can be an effective option to reduce their risk of certain chronic illnesses.
In this video, learn where the stigma of weight-loss medications comes from — and why the stigma should be erased, according to Preeti Parikh, MD, Executive Medical Director at GoodRx.
Preeti Parikh, MD is the Executive Medical Director at GoodRx and served as the Chief Medical Officer of HealthiNation.
References
American College of Cardiology. (2025). American College of Cardiology issues guidance on weight management drugs.
American Society of Health-System Pharmacists. (2023). Semaglutide injection.
Collins, L., et al. (2022). Glucagon-like peptide-1 receptor agonists. StatPearls.
Fulton, M., et al. (2023). Obesity, stigma, and discrimination(archived). StatPearls.
Why trust our experts?
